Filtros de búsqueda

Lista de obras de Jörn M Schattenberg

A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development

artículo científico publicado en 2017

Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo

artículo científico publicado en 2011

Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors.

artículo científico publicado en 2014

Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B

artículo científico publicado en 2012

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

artículo científico publicado en 2020

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

artículo científico publicado en 2016

Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome

artículo científico publicado en 2011

Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis

artículo científico publicado en 2018

Apoptosis in liver disease

scientific article published on 01 October 2006

Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials.

artículo científico publicado en 2018

Assessing the disease burden of non-alcoholic fatty liver disease in the real world - big data and big numbers

scientific article published on 04 July 2019

Association between diabetes mellitus and hepatic encephalopathy in patients with liver cirrhosis

artículo científico publicado en 2020

Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study

scientific article published on 07 January 2021

CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling.

artículo científico publicado en 2004

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein Cholesterol

scientific article published on 30 September 2019

Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.

artículo científico publicado en 2011

Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohort

artículo científico publicado en 2022

Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study

artículo científico publicado en 2016

Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure

artículo científico publicado en 2015

Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents.

artículo científico publicado en 2013

Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells

artículo científico publicado el 4 de julio de 2013

Disclosure behaviour and experienced reactions in patients with HIV versus chronic viral hepatitis or diabetes mellitus in Germany

artículo científico publicado en 2013

Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma

artículo científico publicado el 22 de febrero de 2013

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.

artículo científico publicado en 2012

Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir

artículo científico publicado en 2015

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort

artículo científico publicado en 2015

Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply

artículo científico publicado en 2018

Effectiveness of lifestyle interventions in NAFLD (nonalcoholic fatty liver disease) - how are clinical trials affected?

artículo científico publicado en 2020

Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis.

artículo científico publicado en 2017

Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis

artículo científico publicado en 2020

Epidemiology of hepatic encephalopathy in german hospitals - the EpHE study.

artículo científico

Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis

artículo científico publicado en 2016

Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors

artículo científico publicado en 2016

Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation

artículo científico publicado en 2016

Hepatocyte resistance to oxidative stress is dependent on protein kinase C-mediated down-regulation of c-Jun/AP-1.

artículo científico publicado en 2004

Hepatocyte-specific deletion of IL1-RI attenuatesliver injury by blocking IL-1 driven autoinflammation

artículo científico publicado en 2018

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

artículo científico publicado en 2017

Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany

scientific article published on 03 December 2019

Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program

scientific article published on 25 July 2019

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany

artículo científico publicado en 2020

Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

artículo científico publicado en 2014

Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP

scientific article published on 14 June 2012

Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease.

artículo científico

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

artículo científico publicado en 2006

Leptomeningeal familial amyloidosis: A rare differential diagnosis of leptomeningeal enhancement in MRI

scientific article published on 21 September 2006

Liver injury in COVID-19: The current evidence

scientific article published on 01 June 2020

Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)

artículo científico publicado en 2010

Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct-ligation.

artículo científico publicado en 2017

Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis.

artículo científico publicado en 2017

Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation

artículo científico publicado en 2012

Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH

artículo científico publicado en 2019

NAFLD - sounding the alarm on a silent epidemic

artículo científico publicado en 2020

NAFLD between genes and environment: what drives fibrogenesis?

artículo científico publicado en 2020

New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factor

artículo científico publicado en 2015

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease

artículo científico publicado en 2020

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

artículo científico

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression

scientific article published on 22 June 2020

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)

artículo científico publicado en 2019

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment

artículo científico publicado en 2016

Patterns of liver injury in COVID-19 - a German case series

artículo científico publicado en 2020

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany

article

Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

artículo científico publicado en 2020

Prime time for medical therapy in NASH?

artículo científico publicado en 2016

Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH)

artículo científico publicado en 2020

Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based study

scientific article published on 30 July 2020

Reading the stars for hepatic fibrosis or how to predict the severity of liver disease in patients with NASH

artículo científico publicado en 2019

Refining Noninvasive Diagnostics In Nonalcoholic Fatty Liver Disease: Closing the Gap to Detect Advanced Fibrosis

artículo científico publicado en 2019

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling.

artículo científico publicado en 2014

Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.

artículo científico publicado en 2009

S2k Guideline non-alcoholic fatty liver disease

artículo científico publicado en 2015

Shortcut to death

scientific article published on 01 December 2009

Show me your signaling--and I'll tell you who you are

artículo científico publicado en 2009

Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)

artículo científico publicado en 2019

The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm

artículo científico publicado en 2017

The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease

artículo científico publicado en 2016

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

artículo científico publicado en 2023

The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future success

artículo científico publicado en 2020

The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes.

artículo científico publicado en 2012

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

scientific article published on 01 December 2020

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

artículo científico publicado en 2015

Treatment of malignant ascites with a second cycle of catumaxomab in gastric signet cell carcinoma--a report of 2 cases

artículo científico publicado en 2014

Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance-associated substitutions

artículo científico publicado en 2020

Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieu

artículo científico publicado en 2017

Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters – an animal model of life style intervention in NAFLD

artículo científico publicado en 2019

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study

artículo científico publicado en 2019

[Acute liver failure--medical viewpoints]

artículo científico publicado en 2006

[Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure]

artículo científico publicado en 2015

[Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature]

artículo científico publicado en 2014

[Etiology and complications of liver cirrhosis: data from a German centre].

artículo científico publicado en 2014

[Expected increase of hepatocellular carcinoma by nonalcoholic fatty liver disease]

artículo científico publicado en 2016

[First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology].

artículo científico publicado en 2015

[Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?]

scientific article published on 08 December 2020

[Overt hepatic encephalopathy: extension of therapeutic armamentarium by old friends?]

artículo científico publicado en 2015

[Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome]

artículo científico publicado en 2015